- Home
- CHNR vs OGEN Comparison
CHNR vs OGEN Comparison
Compare CHNR & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- OGEN
- Stock Information
- Founded
- CHNR N/A
- OGEN 1996
- Country
- CHNR Hong Kong
- OGEN United States
- Employees
- CHNR N/A
- OGEN N/A
- Industry
- CHNR Precious Metals
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- OGEN Health Care
- Exchange
- CHNR Nasdaq
- OGEN Nasdaq
- Market Cap
- CHNR 5.2M
- OGEN 4.6M
- IPO Year
- CHNR 1995
- OGEN N/A
- Fundamental
- Price
- CHNR $0.56
- OGEN $0.20
- Analyst Decision
- CHNR
- OGEN
- Analyst Count
- CHNR 0
- OGEN 0
- Target Price
- CHNR N/A
- OGEN N/A
- AVG Volume (30 Days)
- CHNR 50.3K
- OGEN 351.6K
- Earning Date
- CHNR 05-15-2025
- OGEN 05-09-2025
- Dividend Yield
- CHNR N/A
- OGEN N/A
- EPS Growth
- CHNR N/A
- OGEN N/A
- EPS
- CHNR N/A
- OGEN N/A
- Revenue
- CHNR N/A
- OGEN N/A
- Revenue This Year
- CHNR N/A
- OGEN N/A
- Revenue Next Year
- CHNR N/A
- OGEN N/A
- P/E Ratio
- CHNR N/A
- OGEN N/A
- Revenue Growth
- CHNR N/A
- OGEN N/A
- 52 Week Low
- CHNR $0.45
- OGEN $0.16
- 52 Week High
- CHNR $1.13
- OGEN $3.43
- Technical
- Relative Strength Index (RSI)
- CHNR 52.58
- OGEN 52.52
- Support Level
- CHNR $0.51
- OGEN $0.18
- Resistance Level
- CHNR $0.66
- OGEN $0.22
- Average True Range (ATR)
- CHNR 0.05
- OGEN 0.02
- MACD
- CHNR 0.00
- OGEN 0.00
- Stochastic Oscillator
- CHNR 35.87
- OGEN 66.67
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.